For Immediate Release

October 31, 2012

Sumitomo Chemical Reports
Consolidated Financial Results
For the Half-Year Ended September 30, 2012
The Sumitomo Chemical Group’s sales for the half-year ended September 30, 2012were ¥961.4 billion, a decrease of ¥36.9 billion compared with the same period of theprevious fiscal year. Operating income was ¥24.5 billion and ordinary income was¥18.9 billion, both representing a decline from the first half of the previous fiscal year.
The Group recorded a net loss of ¥13.1 billion, which also represents a deteriorationfrom the same period of the previous fiscal year.
Sumitomo Chemical decided to pay an interim dividend of ¥6 per share.
The Sumitomo Chemical Group’s financial results by business segment for thehalf-year were as follows.
Basic Chemicals
Market prices fell for methyl methacrylate and raw materials for synthetic fibers, andshipments of these products also decreased. Sales of aluminum declined due tolower market prices. As a result, the segment’s sales decreased by ¥19.5 billion fromthe same period of the previous fiscal year, to ¥132.9 billion, and operating income
declined by ¥15.1 billion, to a loss of ¥2.6 billion.
Petrochemicals & Plastics
Shipments from a sales subsidiary increased from the previous fiscal year’s level,
which was low due to periodical maintenance shutdowns at the manufacturing plantsof Petro Rabigh in Saudi Arabia. Sales of petrochemical products and synthetic
resins decreased in Singapore and Japan due to lower market prices overseas and adecline in demand at home and abroad. As a result, the segment’s sales rose by ¥2.2billion compared with the same period of the previous fiscal year, to ¥343.2 billion,
but operating income decreased by ¥8.0 billion, to a loss of ¥0.2 billion.
IT-related Chemicals
Shipments of polarizing film used in liquid crystal displays (LCDs) rose, but
shipments of color filters declined. Sales prices of both polarizing film and color
filters dropped. As a result, the segment’s sales decreased by ¥4.5 billion comparedwith the same period of the previous fiscal year, to ¥144.0 billion, and operating
income declined by ¥7.7 billion, to ¥2.4 billion.
Health & Crop Sciences
In the area of crop protection chemicals, shipments of herbicides remained strong inoverseas markets, but sales declined due to seasonal effects caused by a change inan overseas subsidiary’s fiscal year to the end of March from the end of December.
Shipments of pharmaceutical chemicals and the long-lasting insecticidal mosquito
net, Olyset® Net, decreased due to lower demand. Market prices of the feed additive
methionine declined. As a result, the segment’s sales decreased by ¥18.7 billion
compared with the same period of the previous fiscal year, to ¥119.8 billion, andoperating income declined by ¥7.1 billion, to ¥7.7 billion.

Pharmaceuticals
In Japan, despite higher sales of Avapro® (therapeutic agent for hypertension),
Lonasen® (atypical antipsychotic), Trerief® (therapeutic agent for Parkinson’sdisease) and Metgluco® (biguanide oral hypoglycemic), overall sales declined
because of the significant impact of Japanese National Health Insurance drug pricerevisions. In North America, shipments of Xopenex® (short-acting beta-agonist)
decreased as its exclusivity expired, but overall sales rose thanks to strong
shipments of Latuda® (atypical antipsychotic) and Lunesta® (sedative hypnotic), as
well as a receipt of milestone payments of licensing fees. As a result, the segment’ssales increased by ¥1.1 billion compared with the same period of the previous fiscal
year, to ¥194.3 billion, and operating income rose by ¥7.7 billion, to ¥23.1 billion.
OthersIn addition to the above five segments, the Sumitomo Chemical Group engages insupplying electrical power and steam, providing services for the design, engineering,and construction management of chemical plants, providing transport andwarehousing, and conducting materials and environmental analysis. The segment’ssales increased by ¥2.6 billion compared with the same period of the previous fiscal
year, to ¥27.2 billion, and operating income rose by ¥0.7 billion, to ¥4.2 billion.
The Company has revised its consolidated financial forecast of fiscal 2012
announced on July 31, 2012. It now projects sales of ¥2,020.0 billion, operating
income of ¥65.0 billion, ordinary income of ¥62.0 billion, and net income of ¥10.0billion for the full year ending March 31, 2013.
The Company previously projected a year-end dividend of ¥3 per share, but noprojection was made this time because of the revision to the earnings forecast forfiscal 2012. The Company will announce its year-end dividend projection after fullconsideration of its financial forecast for the second half of the current fiscal year andthe next fiscal year that will end March 31, 2014.
For further details, please refer to today’s release titled “Sumitomo ChemicalAnnounces Variances between its Financial Forecast and Actual Results for theHalf-year Ended September 30, 2012 and Revisions to its Financial Forecast andProjected Dividend for Fiscal 2012.”

Summary of Consolidated Results(1) Results of Operations:

Net sales
Operating income
Ordinary income
Income before income taxes
and minority interests
Net loss

Net loss per 1,000 shares
Dividends per 1,000 shares:
Interim dividends

Comprehensive income(2) Financial Position:
Total assets
Total net asset(3) Cash Flows:

Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Cash and cash equivalents at end of period(4) Results of Operations byBusiness Segment:
Net sales
Basic Chemicals
Petrochemicals & PlasticsIT-related Chemicals
Health & Crop Sciences
Pharmaceuticals
OthersOperating income (loss)
Basic Chemicals
Petrochemicals & Plastics
IT-related Chemicals
Health & Crop Sciences
Pharmaceuticals
OthersAdjustments

6 Months ended
September 30，2012
Yen （Millions）
USD (Thousands)*
961,383
12,388,956
24,481
315,477
18,948244,175

6 Months ended
September 30，2011
Yen （Millions）
998,281
54,03548,993

13,634(13,114)

175,696(168,995)

20,636(2,713)

Yen(8,023)

USD*(103)

Yen(1,660)

6,000

77

6,000

Yen （Millions）(11,511)

USD (Thousands)*(148,338)

Yen （Millions）
4,653

As of September 30, 2012
Yen （Millions）
USD (Thousands)*
2,341,617
30,175,477
699,435
9,013,338

As of March 31, 2012
Yen （Millions）
2,336,953
720,901

6 Months ended
September 30，2012
Yen （Millions）
USD (Thousands)*
61,837
796,869(104,821)(1,350,786)
26,143336,894
131,797
1,698,415

6 Months ended
September 30，2011
Yen （Millions）
57,162(60,115)(2,578)146,383

6 Months ended
September 30，2012
Yen （Millions）
USD (Thousands)*

6 Months ended
September 30，2011
Yen （Millions）

132,855
343,186
144,043
119,786
194,272
27,241
961,383

1,712,049
4,422,500
1,856,224
1,543,634
2,503,505
351,044
12,388,956

152,320
340,993
148,588
138,521
193,181
24,678998,281(2,586)
(218)
2,402
7,728
23,1294,195(10,169)
24,481(33,325)(2,809)30,954
99,588298,054
54,059(131,044)
315,477

12,524
7,795
10,083
14,77815,456
3,502(10,103)
54,035(Note)*:U.S. dollar amounts are translated from yen, for convenience only, at the rate of¥77.6= $1 prevailing on September 30, 2012.